You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 5, May 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Unusual Neurotoxicity Associated With Amiodarone Therapy

Prasad R. Palakurthy, MD; Vasudeva Iyer, MD; Roy J. Meckler, MD

Arch Intern Med. 1987;147(5):881-884.


Abstract



• One hundred two patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for nine± eight months (mean ± SD) (range, one to 50 months). Forty-five patients exhibited some form of neurotoxic reaction that was severe enough in nine patients to require discontinuation of treatment or reduction in dosage of the drug. The most frequent neurotoxic findings were tremor (44 patients), peripheral neuropathy (ten patients), and ataxia (seven patients). Five patients developed unusual neurotoxic manifestations: brainstem dysfunction characterized by downbeat nystagmus, hemisensory loss and ataxia, severe dyskinesia, jaw tremor, and proximal myopathy. Neurophysiologic studies revealed varying degrees of predominantly demyelinating peripheral neuropathy. Neurotoxic symptoms improved after discontinuing treatment or decreasing the dosage of the drug. Age of the patient and total cumulative dose did not seem to be risk factors for development of neurotoxicity. These neurotoxic findings suggest that amiodarone-induced neurotoxic reactions are not only confined to the peripheral nervous system, but also that parts of the central nervous system (eg, basal ganglia, brain stem, or their connections) may also be involved.

(Arch Intern Med 1987;147:881-884)



Author Affiliations



From the Division of Cardiology, Department of Medicine (Dr Palakurthy) and the Department of Neurology (Drs Iyer and Meckler), University of Louisville School of Medicine.


Footnotes



Accepted for publication Oct 22, 1986.

Reprint requests to the Division of Cardiology, 550 S Jackson, Louisville, KY 40292 (Dr Palakurthy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
Orr and Ahlskog
Arch Neurol 2009;66:865-869.
ABSTRACT | FULL TEXT  

Amiodarone-induced neurotoxicity
Willis and Lugo
Am J Health Syst Pharm 2009;66:567-569.
ABSTRACT | FULL TEXT  

Ataxia caused by amiodarone in older people
Hindle et al.
Age Ageing 2008;37:347-348.
ABSTRACT | FULL TEXT  

Arm Restlessness as the Initial Symptom in Restless Legs Syndrome
Freedom and Merchut
Arch Neurol 2003;60:1013-1015.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.